B

Biogen

Develops therapies for neurological disorders

Global Commercialization Lead - SMA

Product MarketingConfirmed live in the last 24 hours
Full-timeCambridge, MA, USAHybrid

About the Job

Requirements

  • A bachelor's degree in business, life sciences, or a related discipline.
  • At least 15 years of experience in the pharmaceutical or biotechnology industry.
  • Direct affiliate in-market experience and at least five years of experience outside the United States.
  • Proven experience in biotechnology product launches.
  • Experience in rare diseases, transplant, neurology, and immunology therapeutic areas.

Responsibilities

  • Develop and lead the global commercialization strategy across multiple regions.
  • Own the short-term brand plan, focusing on revenue maximization and supporting annual revenue targets.
  • Lead the Global Marketing team in delivering campaigns, messages, and marketing initiatives.
  • Provide commercial input to long-term strategic decisions, including lifecycle management and asset value maximization.
  • Partner with regions and affiliates to deliver on country-specific needs and optimize asset value.
  • Conduct competitive workshops and market assessments to inform strategic decisions.
  • Engage with external stakeholders, including clinicians, policy stakeholders, and advocacy groups.
  • Drive cross-functional alignment and collaboration across marketing, medical, and market access teams.
  • Ensure launch planning, readiness, and execution are effectively managed.
  • Operate within a Product Development & Commercialization model.

Desired Qualifications

  • Strong profit and loss experience.
  • An advanced degree such as an MBA, Master of Science, or PhD.
  • Experience with strategic financial trajectory planning.
  • A background in engaging with external partners and stakeholders.

About the Company

Biogen

Develops therapies for neurological disorders

Biogen is a global biotechnology company focused on neuroscience. It discovers, develops, and delivers therapies for neurological disorders, such as multiple sclerosis and other neurodegenerative diseases. Its product process starts with research and development to identify potential drugs, followed by clinical testing and regulatory approval, ultimately leading to commercialization and patient treatment. Biogen differentiates itself through a long history (founded in 1978), a deep specialization in neuroscience, and an integrated pipeline that moves ideas from discovery to approved medicines, aiming to create value for shareholders while helping communities. The company’s goal is to advance therapies for neurological diseases to improve patients’ lives and generate sustainable value for stakeholders.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
1978

Recently Posted Jobs

Explore more opportunities at Biogen

See more jobs